Concepedia

Publication | Open Access

Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis

DOIFull Paper Access

60

Citations

29

References

2009

Year

Karin Przyklenk, Andrew L. Frelinger, Matthew D. Linden, Peter Whittaker, Y. LI, M.R. BARNARD, John Adams, Michael Morgan, Hussien Al‐Shamma, Alan D. Michelson
Journal of Thrombosis and Haemostasis

Abstract

5HT2A receptor inhibition with APD791, even when initiated after the onset of recurrent thrombosis, improves coronary patency in the in vivo canine model.

References

YearCitations

Page 1